Sarcoma Human Myometrium Total RNA, Donor 2096 (CAT#: DBFF-0624-HY5580)

Datasheet

Overview

Sarcoma is a malignant tumor originating in the mesenchymal tissue. It is an aggressive tumor with a high degree of malignant transformation. Sarcoma Human Myometrium Total RNA, Donor 2096 is extracted from myometrium tissue of a single sarcoma human donor using a classical guanidine isothiocyanate-phenol: chloroform extraction method. RNA goes through rigorous quality control procedures to ensure the highest quality possible.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Female

Age At Sampling

48 yrs

Medical Diagnosis

Leiomyosarcoma

Product Description

Species

Human

Tissue Name

Myometrium

Sample Diagnosis Category

Sarcoma

28S/18S Ratio

1.38

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Northern blotting, ribonuclease protection assay, polymerase chain reaction analysis, rapid amplification of cDNA end analysis, cDNA synthesis, RNA differential display, microRNA studies, and RNA library construction.

Product Properties

Normal Ratio

Lesional Ratio

Tumor Ratio

80%

Hypocellular/Acellular Tumor Stroma Ratio

Hypercellular Tumor Stroma Ratio

Necrosis Ratio

20%

Histopathological Grade

FIGO G3: Poorly differentiated

Tumor Stage

Primary Tumor (T)

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use